Dow Down 0.25% Nasdaq Down 0.14%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.16 Down 0.01(0.85%) Sep 29, 4:00PM EDT
Prev Close:1.17
Open:1.19
Bid:1.00 x 2100
Ask:1.20 x 20000
1y Target Est:1.67
Beta:0.71
Next Earnings Date:N/A
Day's Range:1.14 - 1.20
52wk Range:1.00 - 2.35
Volume:128,952
Avg Vol (3m):565,156
Market Cap:60.05M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVEO

Comparison

Symbol% ChgMkt Cap
AVEODown 0.85%60.05M
AMGNDown 0.70%106.40B
PFEUp 0.17%188.77B
RHHBYDown 0.24%250.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.92
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback